QRC-PVD Clinical Trial - Telmisartan in the Management of Abdominal Aortic Aneurysm (TEDY)
- Courses
- Future Students
- Current Students
- Research and Teaching
- Partners and Community
- About JCU
- Celebrating 50 Years
- Anton Breinl Research Centre
- Agriculture Technology and Adoption Centre
- Living on Campus
- Advanced Prawn Breeding Research Hub
- Advanced Analytical Centre
- Applying to JCU
- Alumni
- AMHHEC
- Australian/NZ Students
- Australian Lions Stinger Research
- Boating and Diving
- Australian Tropical Herbarium
- ATSIP
- Careers at JCU
- Association of Australian University Secretaries
- Careers and Employability
- Australian Quantum & Classical Transport Physics Group
- CITBA
- Centre for Tropical Bioinformatics and Molecular Biology
- Chancellery
- CMT
- CASE
- College of Business, Law and Governance
- College of Healthcare Sciences
- College of Medicine and Dentistry
- College of Science and Engineering
- CPHMVS
- COVID-19 Advice
- CSTFA
- Centre for Disaster Solutions
- Daintree Rainforest Observatory
- Diploma of Higher Education
- Discover Nature at JCU
- Division of Research and Innovation
- Division of Tropical Environments and Societies
- Division of Tropical Health and Medicine
- Staff Intranet
- Economic Geology Research Centre
- Elite Athletes
- Estate
- Fletcherview
- Foundation for Australian Literary Studies
- Gender Equity Action and Research
- GetReady4Uni
- Give to JCU
- Information for JCU Cairns Graduates
- Graduate Research School
- Graduation
- JCU Ideas Lab
- Indigenous Education and Research Centre
- Indigenous Legal Needs Project
- IT Services
- Information for Agents
- International Students
- JCU College
- JCU Contact Information
- JCU Eduquarium
- JCU Global Experience
- JCU Motorsports
- JCU Prizes
- JCU Sport
- Language and Culture Research Centre
- LTSE
- LearnJCU
- Library
- MARF
- Marine Geophysics Laboratory
- New Students
- Off-Campus Students
- Office of the Provost
- Office of the Vice Chancellor and President
- Open Day
- Orpheus
- Outstanding Alumni Awards
- Parents and Partners
- Pathways to University
- Planning and Performance
- Planning for your future
- Placements
- Policy
- PAHL
- Publications
- Professional Experience Placement
- Queensland Research Centre for Peripheral Vascular Disease
- Rapid Assessment Unit
- Researcher Development Portal
- JCU Connect
- Safety and Wellbeing
- Scholarships @ JCU
- SICEM
- Staff
- Student Equity and Wellbeing
- TESS
- TREAD
- TropEco
- TQ Maths Hub
- TUDLab
- Unicare Centre and Unicampus Kids
- UAV
- VAVS Home
- Work Health and Safety
- WHOCC for Vector-borne & NTDs
- Media
- Copyright and Terms of Use
- Australian Institute of Tropical Health & Medicine
This study aimed to see whether a medication, Telmisartan, can reduce the growth of small (35-49cm) abdominal aortic aneurysms (AAA).
Recruitment status
Recruitment closed
The only treatment available for AAA is surgical repair. Surgery is associated with a number of complications and is only performed on patients who have a high risk of bursting their AAA. Abdominal aortic aneurysms slowly grow over time and at the commencement of this study, there were no current pharmaceuticals which slowed their growth.
Consenting participants (230) attended our study centres a minimum of 7 times over 24 months as part of this study, which took place over six years.
The data collected from this study is still being analysed. Results will be published in peer-reviewed journal articles and communicated to participants.
See also:
Morris, D. et al. (2015) TElmisartan in the management of abDominal aortic aneurYsm (TEDY): the study protocol for a randomised controlled trial. Trials, 16:274 [doi:10.1186/s13063-015-0793-z]